Moreover, E2F1 was a prognostic maker of neuroblastoma independent of MYCN amplification, age of diagnosis and E2F3 expression in TARGET, GSE85047 and E-MTAB-1781 datasets (Fig. 4d). This evidence concerns the gene E2F3 and neuroblastoma.